Spasmolytic Polypeptide‐Expressing Metaplasia in Chronic Atrophic Gastritis and Its Role in the Progression From Gastritis to Gastric Cancer
Journal of Digestive Diseases · 2026
DOI: 10.1111/1751-2980.70060 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Digestive Diseases, 2026. Verfasst von Xin Quan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Gastritis, Atrophic, Precancerous Conditions, Peptides. Die Arbeit nennt 124 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: West China Hospital, Sichuan University.
Abstract (Originalsprache)
Chronic atrophic gastritis (CAG) is a well‐recognized precursor of gastric cancer (GC). Spasmolytic polypeptide‐expressing metaplasia (SPEM) is a key intermediate state during this process, representing a reparative response to gastric mucosal injury, and may promote the development of malignancy under persistent inflammation. Recent studies have suggested that SPEM is not a static lesion but a dynamic and heterogeneous process regulated by epithelial injury, oxyntic atrophy, and chronic inflammation. This review summarizes current knowledge on cellular plasticity, lineage dynamics, and molecular mechanisms underlying SPEM formation and progression in CAG. We focus on recent advances in oxyntic atrophy, immune cell and inflammation, as well as oxidative stress in gastric epithelial remodeling, and highlight emerging evidence implicating ferroptosis, a regulated form of iron‐dependent lipid peroxidation, in gastric mucosal inflammation and SPEM development. By integrating classical models of GC with recent mechanistic insights, we aim to discuss the role of SPEM in CAG‐associated GC risk and to identify potential therapeutic targets related to oxyntic atrophy, inflammation, and ferroptosis. These emerging findings offer new perspectives for future research aiming at risk stratification and precision prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
- Department of Clinical Nutrition, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
- The Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
ORCID-Profile: Ling Liu
Förderung
- West China Hospital, Sichuan University
Zitieren
APA
Quan, X., Ji, L. L., He, T., Liu, J., Shi, L., & Liu, L. (2026). Spasmolytic Polypeptide‐Expressing Metaplasia in Chronic Atrophic Gastritis and Its Role in the Progression From Gastritis to Gastric Cancer. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.70060
Vancouver
Quan X, Ji LL, He T, Liu J, Shi L, Liu L. Spasmolytic Polypeptide‐Expressing Metaplasia in Chronic Atrophic Gastritis and Its Role in the Progression From Gastritis to Gastric Cancer. Journal of Digestive Diseases. 2026. doi:10.1111/1751-2980.70060
BibTeX
@article{Quan2026,
author = {Quan, Xin and Ji, Ling Long and He, Tian and Liu, Jiao and Shi, Lei and Liu, Ling},
title = {Spasmolytic Polypeptide‐Expressing Metaplasia in Chronic Atrophic Gastritis and Its Role in the Progression From Gastritis to Gastric Cancer},
journal = {Journal of Digestive Diseases},
year = {2026},
doi = {10.1111/1751-2980.70060}
}
EUVIMED